Natixis Advisors
VCYT icon

Natixis Advisors’s Veracyte VCYT Stock Holding History

Natixis Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
44,686
+9,182
+26% +$385K ﹤0.01% 1134
2026
Q1 		$1.14M Buy
35,504
+5,643
+19% +$209K ﹤0.01% 1311
2025
Q4 		$1.26M Buy
29,861
+2,038
+7% +$82.2K ﹤0.01% 1191
2025
Q3 		$955K Buy
+27,823
New +$798K ﹤0.01% 1333

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Natixis Advisors's VCYT Position: Q2 2026 in Review

Natixis Advisors increased its Veracyte (VCYT) stake by 26% in Q2 2026, buying an estimated $385K and bringing the position to 44,686 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Natixis Advisors first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Natixis Advisors held 44,686 shares of Veracyte worth $2.62M as of Q2 2026.
  • Natixis Advisors bought 9,182 Veracyte shares in Q2 2026, an estimated $385K.
  • Veracyte made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1134 holding.
  • Natixis Advisors first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.